Quantitative measurement of particles present in the different potencies is performed using DLS, as shown in Figure -D. To measure particle size, we have taken the solution in two different parts of the glass bottle (top and bottom part), as described earlier. Most of the particles are in size in the upper portion of the bottle (~200-600 nm) (Figure ). However, mostly large size (~6µm) particles are found (Figure ). The distribution of particle size decreases (size range of particles present) as the potency increases. It is important to note that the bulk particle size measurement (large sample volume) using DLS clearly shows the non-uniform size distribution of particles in the solution (top and bottom part). Hence, during the potentization process, we take the solution from the top part, i.e., smaller particles. Hence, potentization results in solutions with smaller particles, which improves the effectiveness of the medicine on human health. We have measured the particle size in different successions, as shown in Figure (upper and lower parts of the bottle). Interestingly, we have seen that in the upper part of the bottle, the average size of the particles decreases with an increase of successions number. Hence, more active nanoparticles are exposed to the surface. However, in the lower part, the size of the particle increases with succession during potentization. This result indicates an increase in the air-bubble formation and a mixture of nanoparticles with bubbles.